The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027 · see citing works

α-synuclein locus duplication as a cause of familial Parkinson's disease

Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029 · see citing works

A systematic review of prevalence studies of dementia in Parkinson's disease

Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689 · see citing works

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 2× · see citing works

Glial reactions in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

Chen, H., Zhang, S. M., Hernán, M. Á., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 630 · see citing works

Inflammation as a causative factor in the aetiology of Parkinson's disease

Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 625 · see citing works

Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention

Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 580 · see citing works

NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies

McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498 · see citing works

Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal

Hardy, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s317 · Cited by 475 · see citing works

Neuroinflammatory processes in Parkinson's disease

Hunot, S., & Hirsch, É. C. (2003) · Annals of Neurology · doi:10.1002/ana.10481 · Cited by 399 · see citing works

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

Ishizawa, T., Mattila, P. M., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 391 · see citing works

Dementia in Parkinson disease

LIEBERMAN, A. N., Dziatolowski, M., Kupersmith, M. J., Serby, M., Goodgold, A. L., Korein, J., & Goldstein, M. (1979) · Annals of Neurology · doi:10.1002/ana.410060409 · Cited by 369 · see citing works

Accumulation of Phosphorylated α-Synuclein in Aging Human Brain

Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 351 · see citing works

Neuroinflammatory processes in Parkinson's disease

Hirsch, É. C., Hunot, S., & Hartmann, A. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.013 · Cited by 298 · see citing works

Frequency of Dementia in Parkinson Disease

Aarsland, D., Tandberg, E., Larsen, J. O., & Cummings, J. L. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550060082020 · Cited by 276 · see citing works

Concurrence of α-synuclein and tau brain pathology in the Contursi kindred

Duda, J. E., Giasson, B. I., Mabon, M. E., Miller, D. C., Golbe, L. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0563-3 · Cited by 274 · see citing works

Interface between tauopathies and synucleinopathies: A tale of two proteins

Galpern, W. R., & Lang, A. E. (2006) · Annals of Neurology · doi:10.1002/ana.20819 · Cited by 262 · see citing works

Psychiatric disturbances in Parkinson's disease.

Celesia, G. G., & Wanamaker, W. M. (1972) · PubMed · Cited by 236 · see citing works

Non-steroidal anti-inflammatory drugs in Parkinson's disease

Esposito, E., Matteo, V. D., Benigno, A., Pierucci, M., Crescimanno, G., & Giovanni, G. D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 232 · see citing works

DEMENTIA IN PARKINSON'S DISEASE

Marttila, R. J., & Rinne, U. K. (1976) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1976.tb04375.x · Cited by 193 · see citing works

In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?

Chesselet, M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.08.006 · Cited by 186 · see citing works

More than just two peas in a pod: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases

Lee, V. M. ‐., Giasson, B. I., & Trojanowski, J. Q. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.01.007 · Cited by 185 · see citing works

THE PREVALENCE, NATURAL HISTORY AND DEMENTIA OF PARKINSON'S DISEASE

Pollock, M., & Hornabrook, R. W. (1966) · Brain · doi:10.1093/brain/89.3.429 · Cited by 185 · see citing works

Neuroinflammatory perspectives on the two faces of Alzheimer?s disease

Eikelenboom, P., & van Gool, W. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0055-1 · Cited by 181 · see citing works

Cell systems and the toxic mechanism(s) of α-synuclein

Cookson, M., & van der Brug, M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.022 · Cited by 173 · see citing works

Update on the genetics of Parkinson's disease

Gasser, T. (2007) · Movement Disorders · doi:10.1002/mds.21676 · Cited by 167 · see citing works

Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells

Klegeris, A., Giasson, B. I., Zhang, H., Maguire, J. A., Pelech, S., & McGeer, P. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-6183com · Cited by 143 · see citing works

Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease

Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M., & Ritz, B. R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.836 · Cited by 143 · see citing works

Parkinson's Disease in Patients With Alzheimer's Disease

Leverenz, J. B., & Sumi, S. M. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520070020010 · Cited by 141 · see citing works

Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease

Morris, J. C. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420071025 · Cited by 138 · see citing works

Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam

Forman, M. S., Schmidt, M. L., Kasturi, S. S., Perl, D. P., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61119-4 · Cited by 127 · see citing works

Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms

Hutton, M. L. (2001) · Neurology · doi:10.1212/wnl.56.suppl_4.s21 · Cited by 125 · see citing works

α-Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism-Dementia Complex of Guam

Yamazaki, M., Arai, Y., Baba, M., Iwatsubo, T., Mori, O., Katayama, Y., & Oyanagi, K. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.7.585 · Cited by 98 · see citing works

Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies

Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 91 · see citing works

Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs

Attems, J., Quass, M., & Jellinger, K. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0146-9 · Cited by 84 · see citing works

Parkinson's disease and inflammatory changes

Barcia, C., Barreiro, A. F., Poza, M., & Herrero, M. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033170 · Cited by 76 · see citing works

Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences

Beyer, K., & Ariza, A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181587d64 · Cited by 72 · see citing works

Inhibitors of α-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson’s disease and related disorders

Amer, D. A. M., Irvine, G. B., & El‐Agnaf, O. M. A. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0539-y · Cited by 62 · see citing works

Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms

Halliday, G. M., & McCann, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.006 · Cited by 48 · see citing works

Parkin Disrupts the α-Synuclein/Dopamine Transporter Interaction: Consequences Toward Dopamine-induced Toxicity

Moszczyńska, A., Saleh, J., Zhang, H., Vukusic, B., Lee, F. J. S., & Liu, F. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0037-0 · Cited by 44 · see citing works

Physiological activities of carbon monoxide‐releasing molecules: Ça ira

Chatterjee, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707185 · Cited by 11 · see citing works

Missense and Splice Site Mutations in Tau Associated with FTDP-17 Multiple Pathogenic Mechanisms

Hutton, M. L., Lovestone, S., Heutink, P., Pickering-Brown, S. M., & Yen, S. H. (2000) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04056-0_4 · Cited by 6 · see citing works

Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria

Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972 · see citing works

Peripheral cytokines profile in parkinson’s disease

Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.003 · Cited by 547 · see citing works

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524 · see citing works

Inflammation in Parkinson’s disease: role of glucocorticoids

Herrero, M.-T., Estrada, C., Maatouk, L., & Vyas, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00032 · Cited by 175 · see citing works

The Role of Neuroinflammation in Dementias

Pasqualetti, G., Brooks, D. J., & Edison, P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0531-7 · Cited by 133 · see citing works

Beneficial Effects of Spirulina Consumption on Brain Health

Trotta, T., Porro, C., Cianciulli, A., & Panaro, M. A. (2022) · Nutrients · doi:10.3390/nu14030676 · Cited by 98 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Epidemiology of Clinical Allergy

Burr, M. L. (1993) · Monographs in allergy · doi:10.1159/isbn.978-3-8055-5601-9 · Cited by 64 · see citing works

EPIWEEK: Stata module to create epidemiological week and equivalent epidemiological year

Chu, T. (2010) · RePEc: Research Papers in Economics · Cited by 4 · see citing works

Teaching Epidemiology: What You Should Know and What You Could Do

Olsen, J., & Trichopoulos, D. (1992) · Medical Entomology and Zoology · Cited by 6 · see citing works